The Department of Energy’s (DOE) landmark $17.5 billion loan commitment to fund 10 new Westinghouse reactors and strengthen the domestic nuclear supply chain was expected to trigger a major rally in nuclear sector equities. However, the market’s response has highlighted a significant divergence between policy support and exchange-traded fund (ETF) performance. The two largest retail investment vehicles for this theme have stalled: the Global X Uranium ETF (NYSEARCA:URA) is down 0.56% year-to-date (YTD), while the VanEck Uranium and Nuclear ETF (NYSEARCA:NLR) has dropped 8.31% YTD.
The structural disconnect in URA and NLR
To understand this underperformance, investors must examine the underlying holdings of these funds. URA, the largest ETF in the space with $7.81 billion in net assets as of April 30, 2026, and a 0.69% expense ratio, suffers from heavy concentration risk. A single stock, Cameco, makes up 22.18% of the entire portfolio. Consequently, flows into URA essentially act as a leveraged bet on one Canadian mining firm rather than a diversified play on the domestic nuclear rollout.
Conversely, NLR takes a broader utility-focused approach with a 0.52% expense ratio and a 2.77% dividend yield. However, its largest position is Constellation Energy at 9.62%. Constellation’s earnings are tied directly to wholesale electricity prices rather than reactor building activity or uranium spot prices. This utility ballast dilutes exposure to the upstream supply chain that the DOE capital injection is targeting.
URNM: A direct play on the supply chain
For investors seeking purer exposure to the physical commodity and mining companies, the Sprott Uranium Miners ETF (NYSEARCA:URNM) presents a structurally different alternative. URNM holds 82.37% in uranium equities and 17.63% in physical uranium via the Sprott Physical Uranium Trust. This direct physical sleeve allows spot price changes to reflect instantly in the fund’s Net Asset Value (NAV), bypassing corporate earnings delays.
URNM has gained 15.5% over the past year, outperforming URA’s 12.84% and NLR’s 0.25%. Over a five-year horizon, URNM has delivered a 113.07% return. The trade-offs include a slightly higher expense ratio of 0.75%, a smaller asset base of $2.1 billion, and increased volatility due to the absence of stable utility stocks. URNM is also down 5.45% YTD, reflecting broader sector consolidation.
Tax considerations and portfolio reallocation
Switching holdings between these funds requires careful planning. In taxable accounts, selling URA to buy URNM could trigger significant capital gains liabilities, particularly given URA’s 167.42% return over the past five years. A more tax-efficient approach involves leaving existing allocations intact and directing new capital inflows toward URNM, or executing swaps only within tax-advantaged accounts like IRAs.
Frequently Asked Questions
Why did URA and NLR underperform despite the $17.5 billion government loan?
NLR is heavily weighted toward nuclear utilities like Constellation Energy, which track electricity prices rather than uranium demand. URA is highly concentrated in Cameco (22.18%), making its performance dependent on one corporate entity rather than the broader sector.
How does URNM differ from other uranium ETFs?
URNM allocates 17.63% of its portfolio directly to physical uranium through the Sprott Physical Uranium Trust, giving it direct exposure to spot prices alongside its 82.37% equity sleeve in miners and explorers.
What are the tax risks of switching ETFs?
Selling long-term holdings in URA, which gained 167.42% over the last five years, will trigger capital gains taxes in taxable brokerage accounts. Reallocating within tax-advantaged accounts avoids this immediate liability.
